Search Results (1 to 10 of 2707 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 737 Journal of Medical Internet Research
- 486 JMIR Research Protocols
- 320 JMIR Formative Research
- 238 JMIR mHealth and uHealth
- 105 JMIR Mental Health
- 105 JMIR Public Health and Surveillance
- 97 Online Journal of Public Health Informatics
- 77 JMIR Medical Informatics
- 74 JMIR Human Factors
- 65 JMIR Cancer
- 59 JMIR Pediatrics and Parenting
- 47 JMIR Aging
- 40 JMIR Serious Games
- 38 JMIR Medical Education
- 26 Interactive Journal of Medical Research
- 25 JMIR Perioperative Medicine
- 23 JMIR Diabetes
- 20 JMIR Dermatology
- 18 Iproceedings
- 18 JMIR Infodemiology
- 18 JMIR Rehabilitation and Assistive Technologies
- 13 JMIR Cardio
- 11 JMIR AI
- 11 Journal of Participatory Medicine
- 10 JMIR Nursing
- 7 JMIR Bioinformatics and Biotechnology
- 7 JMIRx Med
- 4 JMIR Biomedical Engineering
- 3 Medicine 2.0
- 2 Asian/Pacific Island Nursing Journal
- 2 JMIR XR and Spatial Computing (JMXR)
- 1 JMIR Neurotechnology
- 0 iProceedings
- 0 JMIR Preprints
- 0 JMIR Challenges
- 0 JMIR Data
- 0 JMIRx Bio
- 0 Transfer Hub (manuscript eXchange)

Of over 3000 potential donors referred between 2010 and 2015, approximately 10% had increased risk behaviors for blood-borne viruses (hepatitis B, hepatitis C, and HIV), but the majority were deemed not medically suitable for organ donation without specific testing to confirm or refute virus exposure [16]. Those potential donors who were tested showed a
Schema of the NSW deceased organ donor referral process. NSW: New South Wales.
JMIR Res Protoc 2025;14:e67588
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section

Primary and secondary outcomes for the smartphone study
aa RR: adjusted risk ratio.
b TM: text messaging.
c Not available.
d PN: patient navigation.
Primary and secondary outcomes for the nonsmartphone study.
aa RR: adjusted risk ratio.
b Not available.
c PN: patient navigation.
J Med Internet Res 2025;27:e74145
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section

First-line laboratory screen: full blood count, C-reactive protein, renal, liver, and thyroid function tests, blood glucose, creatine phosphokinase, and iron measurement, and drug screen of urine. Repeated laboratory screening, as indicated by the treating physician. Tr: trial reduction of lorazepam. T0a: allocated treatment with lorazepam for 4 days. T0b: allocated treatment with sodium oxybate for 4 days after reduction of lorazepam.
JMIR Res Protoc 2025;14:e68356
Download Citation: END BibTex RIS

Terminology and Definitions of Racial Health Equity in Prominent Health Websites: Systematic Review
J Med Internet Res 2025;27:e64868
Download Citation: END BibTex RIS

Participants completed weekly measurements during a baseline phase (phase A, a minimum of 4, 5, or 6 measurements), an intervention period (phase B [PCIT] and phase B’ [PCIT with the addition of VR]), and a follow-up phase (phase C with 3 measurements) that took place 6 months posttreatment. Between phases, a more extensive measurement took place as a way to assess pretreatment, posttreatment, and follow-up group differences as well (Figure 1).
JMIR Pediatr Parent 2025;8:e60752
Download Citation: END BibTex RIS

Grab Bar Grasp Location During Bathtub Exit and Sit-to-Stand Transfers: Biomechanical Evaluation
(C) Horizontal grab bar grasp locations during perturbation exits for HH and SH. (D) Vertical and horizontal grab bar grasp locations during STS. (E) Incline grab bar grasp locations during sit-to-stand. HH: high horizontal; LH: low horizontal; SH: standard horizontal; VRT: vertical.
JMIR Rehabil Assist Technol 2025;12:e69442
Download Citation: END BibTex RIS

In cases with more than two measurements, the last score within 365 days was used (see Section C in Multimedia Appendix 1). Prediction modeling was based on validated Dutch OQ-45 cutoff scores to assess a clinically relevant decrease in symptoms between two measurements (reliable change index: a decrease of at least 14 points in total score) [45,47].
J Particip Med 2025;17:e67170
Download Citation: END BibTex RIS